All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Now is a good time to be involved with type 1 diabetes (T1D) research, according to a U.K. biotech that hopes to reduce or cut the need for insulin injections to treat the condition.
